Article
The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions.
2022-01-25
Abstract excerpt
<h4>Background: </h4> Many available medicines have been evaluated as potential repurposed treatments for coronavirus disease 2019 (COVID-19). We summarise the registered study landscape for 32 priority pharmacological treatments identified following consultation with external experts of the COVID-19 Clinical Research Coalition. <h4>Methods: </h4>: All eligible trial registry records identified by systematic sear...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 39d4147b-4c2b-53ad-b325-9f5b4096c15c
- DOI
- 10.12688/wellcomeopenres.17284.1
